Team makes stem-cell breakthrough


A medical team has confirmed that dopamine-generating cells derived from human induced pluripotent stem cells (iPSC) survived for six months in a monkey brain affected by Parkinson’s disease.

The breakthrough marks a step forward in regenerative medicine using iPSCs to treat humans, the research team, which included members from the Kyoto University Center for iPS Cell Research and Application, said Tuesday.

The team also found the time the monkey was mobile increased 10 percent.

In the absence of way to prevent the decline of dopamine-generating cells, iPSC treatment is expected to be useful against Parkinson’s.